|
Post by awesomo on Apr 12, 2019 14:18:22 GMT -5
Obviously the shorts are starting to feel the pressure that time to get out was yesterday ... and today low volume makes it very difficult to do so. Now down about 16 cents on 2.5M shares. Probably sports boat is getting very full ... but, I have enough shares and can wait for a lower price ... or not. But, that's mytakeonit Pretty sure the shorts are feeling A-Ok about staying in with the PPS down 9% today and dismal script numbers... But hey, just yet another buying opportunity.
|
|
|
Post by ktim on Apr 12, 2019 14:19:42 GMT -5
How come most of these new posters are pushing selling or just dropping Afrezza all together? Does that seem odd to any of the long term holders? We have posters who have been around for a long time and are consistently pessimistic. But now we have many new posters piling on. It could be a legitimate difference in perspective. Someone who bought in recently, perhaps even up on their investment at this point, might think selling off Afrezza unlocks some incremental value and that it could lead to additional short term gains that they'd be perfectly happy taking and moving on to something else. For many long term investors, even if selling off Afrezza doubled the value of MNKD, we'd be way underwater and rather disappointed. Of course it could be those under the evil influence of the dark side of the force.
|
|
|
Post by mnkdfann on Apr 12, 2019 14:23:01 GMT -5
How come most of these new posters are pushing selling or just dropping Afrezza all together? Does that seem odd to any of the long term holders? We have posters who have been around for a long time and are consistently pessimistic. But now we have many new posters piling on. It seems a little odd, if the new posters are also newish investors, insomuch as I would think it would have been the radical / disruptive innovation notion of inhaled insulin / Afrezza that attracted them to MNKD in the first place. But, that may well be me over-simplifying.
|
|
|
Post by ktim on Apr 12, 2019 14:35:47 GMT -5
Obviously the shorts are starting to feel the pressure that time to get out was yesterday ... and today low volume makes it very difficult to do so. Now down about 16 cents on 2.5M shares. Probably sports boat is getting very full ... but, I have enough shares and can wait for a lower price ... or not. But, that's mytakeonit Pretty sure the shorts are feeling A-Ok about staying in with the PPS down 9% today and dismal script numbers... But hey, just yet another buying opportunity. I'm just dreaming about the buying opportunity if we do another R/S. That would be awesomo. Can't understand all these investors that want their companies' products to do well in the market as that deprives one of the buying opportunities. Now I'm heading off to a favorite market for lunch where they have great deals on week old sushi. I eat twice as much because it's half priced. What a bargain.
|
|
|
Post by mango on Apr 12, 2019 15:15:57 GMT -5
How come most of these new posters are pushing selling or just dropping Afrezza all together? Does that seem odd to any of the long term holders? We have posters who have been around for a long time and are consistently pessimistic. But now we have many new posters piling on. We don't need to sell of Afrezza, and Mike would never just drop it altogether—we are approaching the critical phase of the Peds clinical trial, have prelim data being published from the Levin clinical trial very soon, just had very positive results from the Afrezza-One Drop clinical trial, have the artificial pancreas clinical trials still ongoing, have multiple international projects in the works, have multiple new Afrezza publications in the works, Dr. Kendall has a presentation a very significant event next month, we are about to trigger a milestone payment w/ UT for the undisclosed compound, we have a robust pipeline that can trigger milestones and/or partnerships and/or licensing deals which theoretically would include upfront payments as well, and we just had the ADA update language regarding Afrezza in the SoC which was a positive advancement, despite it being small, but positive nonetheless. When the Peds clinical trial is completed and FDA approves Afrezza for the use in pediatrics w/ T1D scripts will rise very fast, and we will not be able to keep up with the Afrezza chatter that should run parallel to them. At least one or more persons in executive management needs his/her salary/compensation chipped off, at least until we are in a better position financially and have a better revenue stream coming in. Something to keep in mind is—a significant amount of Afrezza scripts are because of Vdex. Vdex has and is having great success, and continue to add new locations on a continual bases. TV ads and racecar sponsoring has yet to show a significant effect, however, we still don't know the how the Special Online Afrezza Prescription Program is doing/effecting the weekly Symphony numbers—however still, despite a sales force and all these advertisement and marketing projects by the Company, I would bet they are not creating a shadow over the presence of Vdex—which to me means, Vdex has consistently proven to be effective and successful while Mike & Team have not. For me it is easy to see what is working and what is not. Vdex is working. Mike & Team's strategy has little time remaining until its conclusion will manifest itself (for me that is end of May). But, that's just my take on it 😉
|
|
|
Post by mytakeonit on Apr 12, 2019 15:24:58 GMT -5
Week old sushi ... ahhh ... perfect food for shorts. If you're not short, then don't eat it.
But, that's almost everyone'stakeonit
|
|
|
Post by sportsrancho on Apr 12, 2019 15:41:03 GMT -5
To me it’s very logical, we need help selling Afrezza so we can use other funds to move TS forward and build a strong company. You can’t keep hitting your head against the wall draining your assets.
|
|
johny
Researcher
Posts: 87
|
Post by johny on Apr 12, 2019 16:21:55 GMT -5
How come most of these new posters are pushing selling or just dropping Afrezza all together? Does that seem odd to any of the long term holders? We have posters who have been around for a long time and are consistently pessimistic. But now we have many new posters piling on. It seems a little odd, if the new posters are also newish investors, insomuch as I would think it would have been the radical / disruptive innovation notion of inhaled insulin / Afrezza that attracted them to MNKD in the first place. But, that may well be me over-simplifying. People becoming more vocal about their ideas on, "pushing selling, or just dropping Afrezza all together", may just be clues of everyone's unique capacity to recover from difficult times. In terms of how were feeling, sometimes we wake up leaning more to the right than left.. its just the way it is.. We see the hands of the clock moving, and we know behind the cover are countless gears making these hands move, to not have an idea that isn't progressing on which way these gears are turning to make these hands move, doesn't seem logical. If one chooses to go against these new ideas, subconsciously to them, they may just be a contrarian, which could be a bad or a good thing. I don't think its some kind of conspiracy.. New posters or not, people just seem to be speaking their minds.
|
|
|
Post by sportsrancho on Apr 12, 2019 16:34:28 GMT -5
I just think it puts the fear in God in people when the scripts are down. I had six DM’s this morning from long time longs saying “are we going to make it, should they sell Afrezza to save the company?” That’s where that comes from. None of them want to sell Afrezza. They are scared. I’m not scared but I don’t want to be diluted to death. I want them to always have Afrezza. I just want them to get some help selling it. OK I’m gonna shut up now I have said that enough today🤣
|
|
|
Post by cretin11 on Apr 12, 2019 23:38:50 GMT -5
Sports I’m coming around to what you’re saying there. Script count evidence is impossible to ignore. But question is, who would be the right partner to help sell it? We were burned once, surely lessons were learned, but there aren’t many potential suitors out there. Would love to be a fly on the wall to hear if we are even considering it, and just as importantly, are there any takers out there with whom we’d consider partnering on it?
|
|
|
Post by cretin11 on Apr 12, 2019 23:45:47 GMT -5
Obviously the shorts are starting to feel the pressure that time to get out was yesterday ... and today low volume makes it very difficult to do so. Now down about 16 cents on 2.5M shares. Probably sports boat is getting very full ... Alas Mytakeonit, if only that were true. But in fact the shorts are feeling no pressure except the pressure of a swelling bank account, and they have no apparent urgency to get out now because the tide is apparently going their direction. Hopefully that will change but we’ve been hoping that for years. Some of us remember when their borrowing rates were well above 50% so we thought they’d really feel the pressure. Well they didn’t, and now with rates near zero we should know better.
|
|
|
Post by morfu on Apr 13, 2019 4:21:45 GMT -5
Sports I’m coming around to what you’re saying there. Script count evidence is impossible to ignore. But question is, who would be the right partner to help sell it? We were burned once, surely lessons were learned, but there aren’t many potential suitors out there. Would love to be a fly on the wall to hear if we are even considering it, and just as importantly, are there any takers out there with whom we’d consider partnering on it? >> Script count evidence is impossible to ignore
Exactly, just look a year back.. there are oscillations between 389 to 519 between the total weekly scripts .. we are at least 20% up if not 40% from there and that is not counting any hidden numbers. It is clear even for the USA Afrezza scripts for adults alone, we are heading towards green numbers in a few years.. not 1, but less than 3 is my guess..
|
|
|
Post by morfu on Apr 13, 2019 4:37:23 GMT -5
Obviously the shorts are starting to feel the pressure that time to get out was yesterday ... and today low volume makes it very difficult to do so. Now down about 16 cents on 2.5M shares. Probably sports boat is getting very full ... Alas Mytakeonit, if only that were true. But in fact the shorts are feeling no pressure except the pressure of a swelling bank account, and they have no apparent urgency to get out now because the tide is apparently going their direction. Hopefully that will change but we’ve been hoping that for years. Some of us remember when their borrowing rates were well above 50% so we thought they’d really feel the pressure. Well they didn’t, and now with rates near zero we should know better. >> the shorts ... the pressure of a swelling bank account
Well they made some money selling short, but at least the naked shorts must pay interest, so their bank accounts are definitely not swelling. And with every cent the price moves up, they get one step closer to be under. Every month they loose about a cent (okay at 2$ share price that would need 6% interest and we are at 2% atm, but it has been 3-10 ct/year over the last couple of years) Some got out, but for a lot of the recent shorts, the share price already was around or below current level and with Mannkind being financially quite stable, they do feel the pressure!
|
|
|
Post by mymann on Apr 13, 2019 7:30:29 GMT -5
Full disclosure, I am not short, I don't do options, calls and lend our shares. 180,000 shares. I sold most of my position couple of weeks ago and bought them back yesterday and some more after calming down and realized why I have been investing in MannKind for over 10 years. When I said put Afrezza on the back burner, I meant was let the social media and users of Afrezza spread the awearness of the best treatment for PWD. It looks like using traditional avertising on TV is not most efficient way to spend our cash. We have so much potential of becoming one of the large Biotech company but we need help.
|
|
|
Post by mymann on Apr 13, 2019 7:32:52 GMT -5
Killing the Golden Goose for one golden egg. Save the Goose.
|
|